{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:07:32Z","timestamp":1782310052610,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nut.2025.112930","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:57:57Z","timestamp":1755824277000},"page":"112930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Diet-related poor nutritional status as a major challenge in the treatment of patients with amyloidosis: A systematic review"],"prefix":"10.1016","volume":"141","author":[{"given":"Anastasia Areti Kyriazopoulou","family":"Korovesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimilia","family":"Pateli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-8102","authenticated-orcid":false,"given":"Kalliopi Anna","family":"Poulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-898X","authenticated-orcid":false,"given":"Kalliopi","family":"Karatzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.nut.2025.112930_bib0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","article-title":"Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol Ther"},{"issue":"10","key":"10.1016\/j.nut.2025.112930_bib0003","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.nut.2015.04.011","article-title":"Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis","volume":"31","author":"Caccialanza","year":"2015","journal-title":"Nutrition"},{"issue":"10038","key":"10.1016\/j.nut.2025.112930_bib0004","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nut.2025.112930_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.arr.2012.11.003","article-title":"Malnutrition and quality of life in older people: a systematic review and meta-analysis","volume":"12","author":"Rasheed","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.nut.2025.112930_bib0006","doi-asserted-by":"crossref","first-page":"d1732","DOI":"10.1136\/bmj.d1732","article-title":"Investigation and management of unintentional weight loss in older adults","volume":"342","author":"McMinn","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.nut.2025.112930_bib0007","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/0148607113501328","article-title":"Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment","volume":"38","author":"Caccialanza","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.nut.2025.112930_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100833","article-title":"Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis","volume":"46","author":"Grigoletti","year":"2022","journal-title":"Curr Probl Cancer"},{"issue":"6","key":"10.1016\/j.nut.2025.112930_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40520-019-01170-1","article-title":"Malnutrition and sarcopenia","volume":"31","author":"Sieber","year":"2019","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"10.1016\/j.nut.2025.112930_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/jcm12020528","article-title":"Pathophysiology, functional assessment and prognostic implications of nutritional disorders in systemic amyloidosis","volume":"12","author":"Dongiglio","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.nut.2025.112930_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506129.2019.1698417","article-title":"Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype","volume":"27","author":"Driggin","year":"2020","journal-title":"Amyloid"},{"issue":"15","key":"10.1016\/j.nut.2025.112930_bib0012","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3390\/jcm10153415","article-title":"Frailty in wild-type transthyretin cardiac amyloidosis: the tip of the iceberg","volume":"10","author":"Broussier","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2012.070359","article-title":"A prospective study of nutritional status in immunoglobulin light chain amyloidosis","volume":"98","author":"Sattianayagam","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.nut.2025.112930_bib0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","article-title":"SARC-F: a simple questionnaire to rapidly diagnose sarcopenia","volume":"14","author":"Malmstrom","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/apm.2018.08.07","article-title":"Measuring cachexia-diagnostic criteria","volume":"8","author":"Dev","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.nut.2025.112930_bib0016","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.nut.2025.112930_bib0017","unstructured":"PROSPERO [Internet]. York: Centre for Reviews and Dissemination, University of York; [cited 2024 Jan 31]. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/"},{"key":"10.1016\/j.nut.2025.112930_bib0018","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.nut.2025.112930_bib0019","unstructured":"Study Quality Assessment Tools | NHLBI, NIH [Internet]. Bethesda (MD): National Heart, Lung, and Blood Institute; [cited 2024 Jan 12]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"10.1016\/j.nut.2025.112930_bib0020","unstructured":"Ottawa Hospital Research Institute [Internet]. Ottawa: Ottawa Hospital Research Institute; [cited 2024 Jan 12]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"2","key":"10.1016\/j.nut.2025.112930_bib0021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcn\/83.2.350","article-title":"Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1","volume":"83","author":"Caccialanza","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0022","first-page":"6","article-title":"Body mass index and treatment response in patients with cardiac light-chain amyloidosis","volume":"2","author":"Kim","year":"2021","journal-title":"J Clin Cardiol"},{"issue":"3","key":"10.1016\/j.nut.2025.112930_bib0023","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-011-1309-x","article-title":"Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis","volume":"91","author":"Caccialanza","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nut.2025.112930_bib0024","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.amjcard.2022.05.003","article-title":"Relation of body mass index to transthyretin cardiac amyloidosis particularly in black and Hispanic patients (from the SCAN-MP study)","volume":"177","author":"Poterucha","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2025.112930_bib0025","series-title":"StatPearls <number>","article-title":"Cardiac amyloidosis","author":"Shams","year":"2023"},{"key":"10.1016\/j.nut.2025.112930_bib0026","article-title":"Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival","volume":"67\u20138","author":"Ryan","year":"2019","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.nut.2025.112930_bib0027","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0300060518814337","article-title":"Multiorgan involvement by amyloid light chain amyloidosis","volume":"47","author":"Li","year":"2019","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2025.112930_bib0029","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2022.01.003","article-title":"Renal amyloidosis: presentation, diagnosis, and management","volume":"135","author":"Gurung","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.nut.2025.112930_bib0030","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2022e12284","article-title":"Renal amyloidosis: a new time for a complete diagnosis","volume":"55","author":"Feitosa","year":"2022","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.nut.2025.112930_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4419486","article-title":"Prevalence and management recommendations for disease-related malnutrition in chronic kidney disease patients with and without diabetes","volume":"2022","author":"Dai","year":"2022","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.nut.2025.112930_bib0032","series-title":"StatPearls","article-title":"Transthyretin amyloid cardiomyopathy (ATTR-CM)","author":"Jain","year":"2024"},{"key":"10.1016\/j.nut.2025.112930_bib0033","article-title":"TTR amyloidosis","volume":"10","author":"Brailovsky","year":"2023","journal-title":"JACC Case Rep."},{"issue":"2_suppl","key":"10.1016\/j.nut.2025.112930_bib0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/2047487320961980","article-title":"Role of gender, age and BMI in prognosis of heart failure","volume":"27","author":"Sciomer","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.nut.2025.112930_bib0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0148607114566854","article-title":"Malnutrition and cachexia in heart failure","volume":"40","author":"Rahman","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"10.1016\/j.nut.2025.112930_bib0036","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12170-013-0353-6","article-title":"New approaches to treating cardiac cachexia in the older patient","volume":"7","author":"Azhar","year":"2013","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4253\/wjge.v13.i1.1","article-title":"Gastrointestinal amyloidosis: a focused review","volume":"13","author":"Dahiya","year":"2021","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.nut.2025.112930_bib0038","unstructured":"Myeloma UK. AL amyloidosis: Melphalan Treatment Guide [Internet]. London: Myeloma UK; 2023 Apr [cited 2025 Jun 14]. Available from: https:\/\/www.myeloma.org.uk\/wp-content\/uploads\/2023\/04\/Myeloma-UK-AL-amyloidosis-Melphalan-Treatment-Guide.pdf"},{"key":"10.1016\/j.nut.2025.112930_bib0039","series-title":"StatPearls","article-title":"Tafamidis","author":"Verma","year":"2025"},{"issue":"1","key":"10.1016\/j.nut.2025.112930_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.nut.2025.112930_bib0041","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900725002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900725002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:30:34Z","timestamp":1762201834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900725002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0899900725002485"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2025.112930","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet-related poor nutritional status as a major challenge in the treatment of patients with amyloidosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2025.112930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112930"}}